ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Yuliang Ran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2555-1311; OpenAlex author ID A5041426946, A5067245729. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper

Papers 3

Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer. Co-author DOI 10.7150/ijms.18736 ↗
CPA4 is a promising diagnostic serum biomarker for pancreatic cancer. Co-author PMID 27073726 ↗
Quercetin Mediates β-Catenin in Pancreatic Cancer Stem-Like Cells. Last author DOI 10.1097/mpa.0000000000000400 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Duxin Sun · 2 shared papers, 2016–2017 · strength 0.14
- Paper Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer. DOI 10.7150/ijms.18736 ↗
- Paper CPA4 is a promising diagnostic serum biomarker for pancreatic cancer. PMID 27073726 ↗
Lichao Sun · 2 shared papers, 2016–2017 · strength 0.14
- Paper Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer. DOI 10.7150/ijms.18736 ↗
- Paper CPA4 is a promising diagnostic serum biomarker for pancreatic cancer. PMID 27073726 ↗
Caineng Cao · 1 shared paper, 2015 · strength 0.06
- Paper Quercetin Mediates β-Catenin in Pancreatic Cancer Stem-Like Cells. DOI 10.1097/mpa.0000000000000400 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.